Research Progress on Prevention and Treatment of Glucolipid Metabolic Disease with Integrated Traditional Chinese and Western Medicine

被引:0
|
作者
GUO Jiao
机构
[1] Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine
[2] Key Unit of Modulating Liver in Treating Hyperlipidemia SACM,Institute of Traditional Chinese Medicine Research Institute,Guangdong Pharmaceutical University
[3] Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine
基金
中国国家自然科学基金;
关键词
glucolipid metabolic disease; liver-based regulatory system for metabolic homeostasis; Tiao Gan(Liver) Qi Shu Hua Zhuo(modulating Gan; trigging key metabolic system to resolve pathogenic factors such as phlegm retention and dampness); Chinese medicine;
D O I
暂无
中图分类号
R58 [内分泌腺疾病及代谢病];
学科分类号
1002 ; 100201 ;
摘要
Hyperlipidemia,type 2 diabetes mellitus,nonalcoholic fatty liver and many other metabolic disorder are frequently co-existing in patients.In addition,these diseases are closely related in pathophysiological settings.However,increasing of the disease incidence,lacking of comprehensive prevention and control measurements against the key pathology point concomitant occurrence with the pattern of the single disease,single target therapy,that is leading therapeutic strategy for these metabolic disorders in the setting of Western medicine(WM).On the basis of the combination of the advantages of integrated Chinese medicine(CM) and WM,with unified understanding of such diseases,the new concept of glucolipid metabolic disease(GLMD) is introduced.In this new concept,disorders in glucose and lipid metabolism are recognized as the key trigger and major driving force for the progress of GLMD.The key points of pathology included dysfunction of neuronal-endocrine-immune system,insulin resistance,oxidative stress,inflammation and intestinal flora imbalance.In the core pathogenic perspective of CM,it can be explained as "Gan(Liver) Shi Shu Xie"(dysfunction of Gan in metabolism and emotion regulation) that will lead to the occurence/production of endogenous dampness and phlegm,blood stasis and turbid.This leads to the new concept of "Liver-based regulatory system for metabolic homeostasis" to be introduced further.The comprehensive prevention and control strategy "Tiao Gan Qi Shu Hua Zhuo"(modulating Gan,trigging key metabolic system to resolve pathogenic factors such as phlegm retention and dampness).Its representative formula Fufang Zhenzhu Tiaozhi Capsule(复方贞术调脂胶囊) is innovated under such rationales.Comment for some commonly-used CM GLMD therapeutic drugs was presented.High-level evidence-based and epidemiological and mechanism studies should be carried out to further interpret and explain of the scientific connotation of GLMD.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 50 条
  • [1] Research Progress on Prevention and Treatment of Glucolipid Metabolic Disease with Integrated Traditional Chinese and Western Medicine
    Guo Jiao
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2017, 23 (06) : 403 - 409
  • [2] Research progress on prevention and treatment of glucolipid metabolic disease with integrated traditional Chinese and Western medicine
    Jiao Guo
    Chinese Journal of Integrative Medicine, 2017, 23 : 403 - 409
  • [3] Research Progress on Prevention and Treatment of Glucolipid Metabolic Disease with Integrated Traditional Chinese and Western Medicine
    GUO Jiao
    Chinese Journal of Integrative Medicine, 2017, 23 (06) : 403 - 409
  • [4] Research progress on the treatment of premature ejaculation by integrated traditional Chinese and Western medicine
    Xu, Peng
    Wang, Jingkai
    Wang, Hailuo
    Zhang, Ruoran
    Pang, Kun
    REVISTA INTERNACIONAL DE ANDROLOGIA, 2024, 22 (03): : 24 - 31
  • [5] Research progress of integrated traditional Chinese and Western medicine in the treatment of advanced gastric cancer
    Ye, Hui-Nan
    Liu, Xiao-Yan
    Qin, Bao-Li
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (01) : 69 - 75
  • [6] Research progress of integrated traditional Chinese and Western medicine in the treatment of advanced gastric cancer
    Hui-Nan Ye
    Xiao-Yan Liu
    Bao-Li Qin
    World Journal of Gastrointestinal Oncology, 2023, 15 (01) : 69 - 75
  • [7] Progress in the treatment of lung adenocarcinoma by integrated traditional Chinese and Western medicine
    Jiang, Hongxin
    Bu, Lina
    FRONTIERS IN MEDICINE, 2024, 10
  • [8] RESEARCH PROGRESS ON THE TREATMENT OF SEPSIS INDUCED MYOCARDIAL INJURY BY INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
    Du, K.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 28 - 28
  • [9] Research progress of traditional Chinese medicine in the treatment of endocrine metabolic diseases in 2023
    Fan, Ming-Yao
    Ru, Jing
    Wang, Si
    Chen, Yan
    Zhang, Xiao-Xia
    Li, Guo-Long
    Hai, Qing-Shan
    Wen, Wei-Bo
    Cui, Huan-Tian
    TRADITIONAL MEDICINE RESEARCH, 2024, 9 (12):
  • [10] Research Progress of Pulmonary Sarcoidosis in Traditional Chinese Medicine and Western Medicine
    苗苹
    杨质秀
    孙宇
    World Journal of Integrated Traditional and Western Medicine, 2022, 8 (06) : 34 - 44